Title : Targeting mTORC1/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of mTORC1/2-Targeted Therapy in Hepatocellular Carcinoma (HCC).

Pub. Date : 2018 May 3

PMID : 29720580






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Notably, AZD8055, but not everolimus, synergistically enhanced the efficacy of 5-FU via reversing 5-FU-induced upregulation of P-glycoprotein (P-gp). Fluorouracil phosphoglycolate phosphatase Mus musculus
2 Notably, AZD8055, but not everolimus, synergistically enhanced the efficacy of 5-FU via reversing 5-FU-induced upregulation of P-glycoprotein (P-gp). Fluorouracil phosphoglycolate phosphatase Mus musculus
3 Notably, AZD8055, but not everolimus, synergistically enhanced the efficacy of 5-FU via reversing 5-FU-induced upregulation of P-glycoprotein (P-gp). Fluorouracil phosphoglycolate phosphatase Mus musculus
4 Notably, AZD8055, but not everolimus, synergistically enhanced the efficacy of 5-FU via reversing 5-FU-induced upregulation of P-glycoprotein (P-gp). Fluorouracil phosphoglycolate phosphatase Mus musculus